Results 261 to 270 of about 12,789,497 (387)

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

Nature Network Boston, 2019
O. Preische, Stephanie A. Schultz, Anja Apel, J. Kuhle, S. Kaeser, Christian Barro, S. Gräber, Elke Kuder-Buletta, C. Lafougère, C. Laske, J. Vöglein, J. Levin, C. Masters, R. Martins, P. Schofield, M. Rossor, N. Graff-Radford, S. Salloway, B. Ghetti, J. Ringman, James M. Noble, J. Chhatwal, A. Goate, T. Benzinger, J. Morris, R. Bateman, Guoqiao Wang, A. Fagan, E. McDade, B. Gordon, M. Jucker, Ricardo Fatima Randall Tammie Sarah Courtney Susan William Allegri Amtashar Bateman Benzinger Berman Bodge Br, R. Allegri, Fatima S. Amtashar, R. Bateman, T. Benzinger, S. Berman, Courtney A. Bodge, S. Brandon, W. Brooks, Jill Buck, V. Buckles, Sochenda Chea, J. Chhatwal, Patricio Chrem, H. Chui, J. Cinco, J. Clifford, Carlos Cruchaga, Mirelle D’Mello, Tamara Donahue, J. Douglas, Noelia Edigo, Nilufer Erekin-Taner, A. Fagan, M. Farlow, Angela M. Farrar, H. Feldman, Gigi Flynn, Nick C Fox, E. Franklin, H. Fujii, Cortaiga Gant, S. Gardener, B. Ghetti, A. Goate, J. Goldman, B. Gordon, N. Graff-Radford, Julia D. Gray, J. Gurney, Jason J Hassenstab, Mie Hirohara, D. Holtzman, R. Hornbeck, Siri Houeland DiBari, T. Ikeuchi, Snezana Ikonomovic, Gina Jerome, M. Jucker, C. Karch, K. Kasuga, T. Kawarabayashi, W. Klunk, R. Koeppe, Elke Kuder-Buletta, C. Laske, Jae-Hong Lee, D. Marcus, R. Martins, N. Mason, C. Masters, Denise Maue-Dreyfus, E. McDade, Lucy Montoya, H. Mori, J. Morris, Akem Nagamatsu, Katie Neimeyer, James M. Noble, J. Norton, R. Perrin, M. Raichle, J. Ringman, J. Roh, S. Salloway, P. Schofield, H. Shimada, Tomoyo Shiroto, M. Shoji, Wendy C. Sigurdson, H. Sohrabi, Paige Sparks, Kazushi Suzuki, Laura M Swisher, K. Taddei, Jen C. Wang, Peter Wang, M. Weiner, Mary A. Wolfsberger, C. Xiong, Xiong Xu   +121 more
semanticscholar   +1 more source

Disease Progression, CTCAE

Definitions, 2020

semanticscholar   +1 more source

Association of histologic disease activity with progression of nonalcoholic fatty liver disease [PDF]

, 2019
Brundt, Elizabeth M, et al,, Kleiner, David E   +2 more
core   +1 more source

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

Molecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo, Marco Siringo, Alessandro Vici, Ann Zeuner, Orietta Gandini, Paola Gazzaniga, Chiara Nicolazzo   +6 more
wiley   +1 more source

Sarcopenia-A Valuable Imaging Biomarker for Disease Progression in Patients With Primary Sclerosing Cholangitis (PSC)? [PDF]

Liver Int
Levers A, Pantke J, Klimeš F, Lenzen H, Düx D, Taubert R, Wedemeyer H, Wacker F, Ringe KI.   +8 more
europepmc   +1 more source

Acceleration of Experimental Autoimmune Encephalomyelitis in Interleukin-10-Deficient Mice: Roles of Interleukin-10 in Disease Progression and Recovery

, 1998
Elena B. Samoilova, Jennifer L. Horton, Youhai Chen   +2 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Dysphagia linked to clinical phenotype and disease progression in spinocerebellar ataxia type 3. [PDF]

Eur J Med Res
Chen CP, Cui ML, Lin W, Huang ZY, Ye BN, Cai B, Gan SR.   +6 more
europepmc   +1 more source

Progression of Parkinson's disease. [PDF]

BMJ, 1990
openaire   +3 more sources

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source